IPSC
HEALTHCARECentury Therapeutics Inc
Live · NASDAQ · May 8, Close
What's Moving IPSC Today?
No stock-specific AI insight has been generated for IPSC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.34
Fundamentals
Trading
IPSC News
20 articles- H.C. Wainwright Remains Bullish on Century Therapeutics (IPSC)Yahoo Finance·May 1, 2026
- Century Therapeutics Selected for Oral Presentation of CNTY‑813 Preclinical Data at the American Diabetes Association 86th Scientific SessionsYahoo Finance·Apr 30, 2026
- Century Therapeutics Reports Full Year 2025 Financial Results and Business UpdatesYahoo Finance·Mar 12, 2026
- Century Therapeutics to Participate in Upcoming Investor Conferences in MarchYahoo Finance·Feb 25, 2026
- Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND SubmissionYahoo Finance·Jan 30, 2026
- Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should KnowYahoo Finance·Jan 22, 2026
- Promising Penny Stocks To Watch In January 2026Yahoo Finance·Jan 16, 2026
- Century Therapeutics Secures Oversubscribed $135 Million Private Placement Financing to Support Lead Program, CNTY-813, a Potentially Curative Therapy for Type 1 DiabetesYahoo Finance·Jan 8, 2026
- FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy DrugYahoo Finance·Jan 7, 2026
- Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a BargainYahoo Finance·Jan 7, 2026
- 3 Promising Penny Stocks With Market Caps Over $30MYahoo Finance·Dec 18, 2025
- Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value InvestorsYahoo Finance·Dec 9, 2025
- Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of DirectorsYahoo Finance·Dec 9, 2025
- Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare ConferenceYahoo Finance·Nov 25, 2025
- Century Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·Nov 13, 2025
- Century Therapeutics Announces New Beta Islet Program for Type 1 DiabetesYahoo Finance·Nov 13, 2025
- Century Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines ConferenceYahoo Finance·Oct 14, 2025
- We Think Century Therapeutics (NASDAQ:IPSC) Needs To Drive Business Growth CarefullyYahoo Finance·Oct 12, 2025
- Century Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment ConferenceYahoo Finance·Aug 22, 2025
- Century Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·Aug 14, 2025
All 20 articles loaded
Price Data
52-Week Range
$2.34
Fundamentals
Trading
About Century Therapeutics Inc
Century Therapeutics Inc. (Ticker: IPSC) is an innovative biotechnology firm at the forefront of advancing allogenic cell therapies aimed at transforming cancer treatment. Utilizing its proprietary induced pluripotent stem cell (iPSC) technology, the company is committed to developing novel off-the-shelf therapeutic solutions that enhance patient outcomes and broaden accessibility. With a robust pipeline of clinical-stage product candidates and strategic partnerships that bolster its competitive edge, Century Therapeutics is strategically positioned to lead advancements in the burgeoning cell therapy market, offering strong potential for clinical successes and favorable returns for investors.